Our previous research demonstrated that PAX6 is regulated by microRNA-223, and the overexpression of PAX6 significantly inhibited glioma cell proliferation and invasion while increasing sensitivity to the chemotherapeutic agent temozolomide [17,18]. The gene discussed is PAX6; the disease is central nervous system cancer.